Gubra

📍 Hoersholm, Denmark🗓 Founded 2008👥 232 employees💰 Last funded Nov 2023
Biotechnology Research🌐 gubra.dk
Website LinkedIn
Founded in 2008, we are a biotech company with two primary areas of business: Preclinical contract research organization (CRO) services and proprietary early target and drug discovery programs. Our focus is the metabolic space (e.g. obesity, diabetes, NASH and gastrointestinal diseases), where we specialize in peptide chemistry, in vivo pharmacology, ex vivo assays, molecular pharmacology, histology, imaging, stereology, NGS (next generation sequencing) and bioinformatics. Gubra is an abbreviation for GUt and BRAin, the original key focus areas of our research and expertise. We work with some of the most interesting and loyal partners and customers from across the world in the pharmaceutical and biotech industry as well as academia. Through a constant focus on high quality, scientific excellence, speed and solid teamwork, we have established ourselves as a highly professional and competent partner in the market.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2008
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Denmark
1
Frequently asked questions
Who invested in Gubra?
Gubra has 1 investors on record on gritt.io.
When did Gubra last raise funding?
The most recent investment in Gubra recorded on gritt.io was in November 2023.
When was Gubra founded?
Gubra was founded in 2008.
What industry is Gubra in?
Gubra operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Gubra based?
Gubra is headquartered in Hoersholm, Denmark.